- Home
- AUPH vs NZF Comparison
AUPH vs NZF Comparison
Compare AUPH & NZF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | NZF |
|---|---|---|
| Founded | 1993 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2014 | 2001 |
Fundamental Metrics
Financial Performance| Metric | AUPH | NZF |
|---|---|---|
| Price | $15.34 | $12.35 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 532.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.54 | N/A |
| Revenue Next Year | $15.74 | N/A |
| P/E Ratio | $62.56 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $8.80 | $11.55 |
| 52 Week High | $19.25 | $13.22 |
Technical Indicators
Market Signals| Indicator | AUPH | NZF |
|---|---|---|
| Relative Strength Index (RSI) | 42.25 | 34.72 |
| Support Level | $14.68 | $12.15 |
| Resistance Level | $16.38 | $12.73 |
| Average True Range (ATR) | 0.63 | 0.08 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 11.69 | 6.44 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About NZF Nuveen Municipal Credit Income Fund
Nuveen Municipal Credit Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and to enhance portfolio value relative to the municipal bond market by investing in an actively managed portfolio of tax-exempt municipal securities.